| Clinical management of uterine sarcomas F Amant, A Coosemans, M Debiec-Rychter, D Timmerman, I Vergote The lancet oncology 10 (12), 1188-1198, 2009 | 560 | 2009 |
| Molecular and translational classifications of DAMPs in immunogenic cell death AD Garg, L Galluzzi, L Apetoh, T Baert, RB Birge, JM Bravo-San Pedro, ... Frontiers in immunology 6, 588, 2015 | 417 | 2015 |
| Wilms' Tumor Gene 1 (WT1)–loaded dendritic cell immunotherapy in patients with uterine tumors: a phase I/II clinical trial A Coosemans, A Vanderstraeten, S Tuyaerts, T Verschuere, P Moerman, ... Anticancer research 33 (12), 5495-5500, 2013 | 304 | 2013 |
| Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study W Froyman, C Landolfo, B De Cock, L Wynants, P Sladkevicius, AC Testa, ... The Lancet Oncology 20 (3), 448-458, 2019 | 196 | 2019 |
| The tale of TILs in breast cancer: a report from the international immuno-oncology biomarker working group K El Bairi, HR Haynes, E Blackley, S Fineberg, J Shear, S Turner, ... NPJ breast cancer 7 (1), 150, 2021 | 181 | 2021 |
| Trial watch: dendritic cell vaccination for cancer immunotherapy J Sprooten, J Ceusters, A Coosemans, P Agostinis, S De Vleeschouwer, ... Oncoimmunology 8 (11), 1638212, 2019 | 149 | 2019 |
| Screening for uterine tumours T Van den Bosch, A Coosemans, M Morina, D Timmerman, F Amant Best practice & research Clinical obstetrics & gynaecology 26 (2), 257-266, 2012 | 142 | 2012 |
| High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification S Olbrecht, P Busschaert, J Qian, A Vanderstichele, L Loverix, T Van Gorp, ... Genome Medicine 13, 1-30, 2021 | 117 | 2021 |
| Chromosomal instability in cell-free DNA as a highly specific biomarker for detection of ovarian cancer in women with adnexal masses A Vanderstichele, P Busschaert, D Smeets, C Landolfo, ... Clinical Cancer Research 23 (9), 2223-2231, 2017 | 101 | 2017 |
| Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study B Van Calster, L Valentin, W Froyman, C Landolfo, J Ceusters, AC Testa, ... Bmj 370, 2020 | 100 | 2020 |
| Trial watch: Dendritic cell (DC)-based immunotherapy for cancer RS Laureano, J Sprooten, I Vanmeerbeerk, DM Borras, J Govaerts, ... Oncoimmunology 11 (1), 2096363, 2022 | 94 | 2022 |
| Myeloid derived suppressor cells: key drivers of immunosuppression in ovarian cancer T Baert, A Vankerckhoven, M Riva, A Van Hoylandt, G Thirion, G Holger, ... Frontiers in Immunology 10, 1273, 2019 | 87 | 2019 |
| Age-related differences in the sonographic characteristics of endometriomas S Guerriero, B Van Calster, E Somigliana, S Ajossa, W Froyman, ... Human reproduction 31 (8), 1723-1731, 2016 | 67 | 2016 |
| Influence of CA125, platelet count and neutrophil to lymphocyte ratio on the immune system of ovarian cancer patients T Baert, J Van Camp, L Vanbrabant, P Busschaert, A Laenen, S Han, ... Gynecologic Oncology 150 (1), 31-37, 2018 | 65 | 2018 |
| Upregulation of Wilms’ tumour gene 1 (WT1) in uterine sarcomas A Coosemans, SA Nik, S Caluwaerts, S Lambin, G Verbist, R Van Bree, ... European Journal of Cancer 43 (10), 1630-1637, 2007 | 56 | 2007 |
| Imaging in gynecological disease (7): clinical and ultrasound features of Brenner tumors of the ovary I Dierickx, L Valentin, C Van Holsbeke, G Jacomen, AA Lissoni, ... Ultrasound in obstetrics & gynecology 40 (6), 706-713, 2012 | 51 | 2012 |
| Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma A Coosemans, A Vanderstraeten, S Tuyaerts, T Verschuere, P Moerman, ... Anticancer research 33 (9), 3855-3859, 2013 | 50 | 2013 |
| Genome-wide association study identifies a possible susceptibility locus for endometrial cancer J Long, W Zheng, YB Xiang, F Lose, D Thompson, I Tomlinson, H Yu, ... Cancer epidemiology, biomarkers & prevention 21 (6), 980-987, 2012 | 48 | 2012 |
| Immunological configuration of ovarian carcinoma: features and impact on disease outcome J Fucikova, A Coosemans, S Orsulic, D Cibula, I Vergote, L Galluzzi, ... Journal for Immunotherapy of Cancer 9 (10), 2021 | 47 | 2021 |
| An autologous dendritic cell vaccine promotes anticancer immunity in patients with ovarian cancer with low mutational burden and cold tumors J Fucikova, M Hensler, L Kasikova, T Lanickova, J Pasulka, J Rakova, ... Clinical Cancer Research 28 (14), 3053-3065, 2022 | 45 | 2022 |